Novo Nordisk A/SNVONYSE
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-28.3%
5Y CAGR-9.8%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
-28.3%/yr
vs +19.0%/yr prior
5Y CAGR
-9.8%/yr
Recent deceleration
Acceleration
-47.3pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 14.11 | -48.8% |
| 2024 | 27.53 | -26.4% |
| 2023 | 37.40 | -2.3% |
| 2022 | 38.27 | +8.2% |
| 2021 | 35.35 | +49.6% |
| 2020 | 23.63 | +0.3% |
| 2019 | 23.57 | +23.6% |
| 2018 | 19.06 | -12.0% |
| 2017 | 21.66 | +27.5% |
| 2016 | 16.99 | - |